Rare diseases
Investigational molecules
Locations
Back to Germany93 clinical trials in Darmstadt, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness and Safety of Brensocatib for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on the Effectiveness and Safety of Taplucainium Inhalation Powder (NOC-110) for Adults with Refractory or Unexplained Chronic Cough
GermanyStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
GermanyStudy of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
GermanyStudy on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
GermanyStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
GermanyStudy on Durvalumab with Radiochemotherapy for Patients with Locally-Advanced Anal Cancer
GermanyStudy on Organ Preservation for Early Stage Esophageal Cancer Using Durvalumab and Chemoradiation for Patients Eligible for Surgery
GermanyStudy on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough
GermanyStudy on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients
GermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on plaque psoriasis and hidradenitis suppurativa, evaluating new therapeutic approaches for chronic skin conditions. Multiple trials are testing novel treatments for moderate to severe cases.
Several innovative compounds being tested including ESK-001, remibrutinib, and JNJ-77242113.
Comprehensive studies addressing severe asthma and COPD, with particular attention to treatments for patients with eosinophilic phenotypes and those requiring advanced care options.
Trials evaluating new inhalation therapies and biological treatments for better disease control.
Advanced studies in acute myeloid leukemia, investigating combination therapies for patients ineligible for intensive chemotherapy. Focus on targeted treatments for specific genetic mutations.
Investigating innovative approaches including revumenib in combination with established treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
